These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 43176)
1. Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings]. Boudot JP; Cavero I; Fénard S; Lefèvre-Borg F; Manoury P; Roach AG Br J Pharmacol; 1979 Jul; 66(3):445P. PubMed ID: 43176 [No Abstract] [Full Text] [Related]
2. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent. Reyes G; Ramírez T; Hong E Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323 [No Abstract] [Full Text] [Related]
3. [Beta-1 and beta-2 blocking activities of a new series of (arylalkoxy) propanolamines]. Rosell G; Mauleón D; Pujol MD; Granados R Arch Farmacol Toxicol; 1986 Apr; 12(1):65-70. PubMed ID: 2874776 [No Abstract] [Full Text] [Related]
5. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders]. Marchetti G; Di Francesco GF; Baldoli E Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253 [No Abstract] [Full Text] [Related]
6. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent. Haustein KO; Fiehring H; Oltmanns G; Femmer K Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294 [No Abstract] [Full Text] [Related]
7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist. Fekete MI; Elekes I; Kürti M; Borvendég J Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers. Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions. Hattori Y; Sakuma I; Nakao Y; Kanno M J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol). Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603 [No Abstract] [Full Text] [Related]
12. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings]. Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556 [No Abstract] [Full Text] [Related]
13. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats. Vanĕcek M; Trcka V; Helfert I Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106 [No Abstract] [Full Text] [Related]
14. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs. Smith RD; Barrett JA; Wolf PS; Pruss TP Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075 [No Abstract] [Full Text] [Related]
18. Influence of beta-adrenoceptor antagonists on spontaneous rate and on force of contraction of isolated rabbit atria. Singh KP Indian J Physiol Pharmacol; 1983; 27(4):311-6. PubMed ID: 6146567 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines. Vo D; Wolowyk MW; Knaus EE Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings]. Bianchetti G; Cadigan PJ; Gomeni R; Kilborn JR; London DR; Morselli PL; Pentecost BL Br J Clin Pharmacol; 1979 Oct; 8(4):403P. PubMed ID: 41555 [No Abstract] [Full Text] [Related] [Next] [New Search]